| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 1474080
[patent_doc_number] => 06387662
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-05-14
[patent_title] => 'Synthesis and purification of hepatitis C virus-like particles'
[patent_app_type] => B1
[patent_app_number] => 09/296441
[patent_app_country] => US
[patent_app_date] => 1999-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 3
[patent_no_of_words] => 11507
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/387/06387662.pdf
[firstpage_image] =>[orig_patent_app_number] => 09296441
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/296441 | Synthesis and purification of hepatitis C virus-like particles | Apr 20, 1999 | Issued |
Array
(
[id] => 4136092
[patent_doc_number] => 06121420
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-09-19
[patent_title] => 'Diagnosis of fungal infections, and a chitin-binding lectin useful in such diagnoses'
[patent_app_type] => 1
[patent_app_number] => 9/290836
[patent_app_country] => US
[patent_app_date] => 1999-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8441
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/121/06121420.pdf
[firstpage_image] =>[orig_patent_app_number] => 290836
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/290836 | Diagnosis of fungal infections, and a chitin-binding lectin useful in such diagnoses | Apr 12, 1999 | Issued |
Array
(
[id] => 4346252
[patent_doc_number] => 06214567
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-10
[patent_title] => 'Immortalized human keratinocyte cell line'
[patent_app_type] => 1
[patent_app_number] => 9/277295
[patent_app_country] => US
[patent_app_date] => 1999-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 15314
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/214/06214567.pdf
[firstpage_image] =>[orig_patent_app_number] => 277295
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/277295 | Immortalized human keratinocyte cell line | Mar 25, 1999 | Issued |
Array
(
[id] => 4366164
[patent_doc_number] => 06287761
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-11
[patent_title] => 'Synthetic antigens for the detection of antibodies to hepatitis C virus'
[patent_app_type] => 1
[patent_app_number] => 9/275265
[patent_app_country] => US
[patent_app_date] => 1999-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 16
[patent_no_of_words] => 12470
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/287/06287761.pdf
[firstpage_image] =>[orig_patent_app_number] => 275265
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/275265 | Synthetic antigens for the detection of antibodies to hepatitis C virus | Mar 22, 1999 | Issued |
Array
(
[id] => 4284611
[patent_doc_number] => 06268124
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-31
[patent_title] => 'Neuronal cell model and methods of use therefor'
[patent_app_type] => 1
[patent_app_number] => 9/272158
[patent_app_country] => US
[patent_app_date] => 1999-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9059
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/268/06268124.pdf
[firstpage_image] =>[orig_patent_app_number] => 272158
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/272158 | Neuronal cell model and methods of use therefor | Mar 18, 1999 | Issued |
Array
(
[id] => 4273230
[patent_doc_number] => 06280940
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-28
[patent_title] => 'Reporter gene system for use in cell-based assessment of inhibitors of the Hepatitis C virus protease'
[patent_app_type] => 1
[patent_app_number] => 9/263933
[patent_app_country] => US
[patent_app_date] => 1999-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 48385
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/280/06280940.pdf
[firstpage_image] =>[orig_patent_app_number] => 263933
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/263933 | Reporter gene system for use in cell-based assessment of inhibitors of the Hepatitis C virus protease | Mar 7, 1999 | Issued |
| 09/262614 | METHOD OF DETECTING THE PRESENCE OF CD155 FOR DIAGNOSIS OF CANCER AND TO DETERMINE TREATMENT | Mar 3, 1999 | Abandoned |
Array
(
[id] => 4349304
[patent_doc_number] => 06291226
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-18
[patent_title] => 'Adenovirus mutants with deleted protease gene'
[patent_app_type] => 1
[patent_app_number] => 9/258209
[patent_app_country] => US
[patent_app_date] => 1999-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 9248
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/291/06291226.pdf
[firstpage_image] =>[orig_patent_app_number] => 258209
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/258209 | Adenovirus mutants with deleted protease gene | Feb 24, 1999 | Issued |
Array
(
[id] => 6176251
[patent_doc_number] => 20020155552
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-24
[patent_title] => '\"PRIONINS\", HIGHLY SPECIFIC MARKERS FOR NONINVASIVE PRE-SYMPTOMATIC DETECTION OF TSE DISEASES, AND TARGETS FOR THERAPEUTIC REAGENTS TO PREVENT AND CONTROL TSE DISEASES IN ANIMALS AND HUMANS'
[patent_app_type] => new
[patent_app_number] => 09/242450
[patent_app_country] => US
[patent_app_date] => 1999-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 8315
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0155/20020155552.pdf
[firstpage_image] =>[orig_patent_app_number] => 09242450
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/242450 | PRIONINS", HIGHLY SPECIFIC MARKERS FOR NONINVASIVE PRE-SYMPTOMATIC DETECTION OF TSE DISEASES, AND TARGETS FOR THERAPEUTIC REAGENTS TO PREVENT AND CONTROL TSE DISEASES IN ANIMALS AND HUMANS | Feb 15, 1999 | Abandoned |
Array
(
[id] => 4401131
[patent_doc_number] => 06231864
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-15
[patent_title] => 'Strategically modified hepatitis B core proteins and their derivatives'
[patent_app_type] => 1
[patent_app_number] => 9/248588
[patent_app_country] => US
[patent_app_date] => 1999-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 13826
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/231/06231864.pdf
[firstpage_image] =>[orig_patent_app_number] => 248588
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/248588 | Strategically modified hepatitis B core proteins and their derivatives | Feb 10, 1999 | Issued |
Array
(
[id] => 4270026
[patent_doc_number] => 06280728
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-28
[patent_title] => 'Treatment of hepatitis C virus infection using a protease and a flavonoid'
[patent_app_type] => 1
[patent_app_number] => 9/245820
[patent_app_country] => US
[patent_app_date] => 1999-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 1925
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/280/06280728.pdf
[firstpage_image] =>[orig_patent_app_number] => 245820
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/245820 | Treatment of hepatitis C virus infection using a protease and a flavonoid | Feb 4, 1999 | Issued |
Array
(
[id] => 4410244
[patent_doc_number] => 06228846
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-08
[patent_title] => 'Polynucleotide vaccine formula against canine pathologies'
[patent_app_type] => 1
[patent_app_number] => 9/232477
[patent_app_country] => US
[patent_app_date] => 1999-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 5290
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/228/06228846.pdf
[firstpage_image] =>[orig_patent_app_number] => 232477
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/232477 | Polynucleotide vaccine formula against canine pathologies | Jan 14, 1999 | Issued |
Array
(
[id] => 4325933
[patent_doc_number] => 06319726
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-20
[patent_title] => 'Immunological method for detecting antibodies directed against tissue transglutaminase (tTG), use of tTG in diagnosis and therapy control, and an oral pharmaceutical agent containing tTG'
[patent_app_type] => 1
[patent_app_number] => 9/229716
[patent_app_country] => US
[patent_app_date] => 1999-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 6829
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/319/06319726.pdf
[firstpage_image] =>[orig_patent_app_number] => 229716
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/229716 | Immunological method for detecting antibodies directed against tissue transglutaminase (tTG), use of tTG in diagnosis and therapy control, and an oral pharmaceutical agent containing tTG | Jan 12, 1999 | Issued |
Array
(
[id] => 7640442
[patent_doc_number] => 06395471
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-05-28
[patent_title] => 'Hepatitis C surrogate virus for testing the activity of hepatitis C virus protease, a recombinant gene and a use thereof'
[patent_app_type] => B1
[patent_app_number] => 09/202904
[patent_app_country] => US
[patent_app_date] => 1998-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 4509
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/395/06395471.pdf
[firstpage_image] =>[orig_patent_app_number] => 09202904
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/202904 | Hepatitis C surrogate virus for testing the activity of hepatitis C virus protease, a recombinant gene and a use thereof | Dec 22, 1998 | Issued |
Array
(
[id] => 4309227
[patent_doc_number] => 06316252
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-13
[patent_title] => 'Biotherapeutic delivery system'
[patent_app_type] => 1
[patent_app_number] => 9/213343
[patent_app_country] => US
[patent_app_date] => 1998-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3898
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/316/06316252.pdf
[firstpage_image] =>[orig_patent_app_number] => 213343
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/213343 | Biotherapeutic delivery system | Dec 16, 1998 | Issued |
Array
(
[id] => 1373910
[patent_doc_number] => 06558899
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-05-06
[patent_title] => 'Method for identifying new anti-picornaviral compounds'
[patent_app_type] => B1
[patent_app_number] => 09/210118
[patent_app_country] => US
[patent_app_date] => 1998-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5091
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/558/06558899.pdf
[firstpage_image] =>[orig_patent_app_number] => 09210118
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/210118 | Method for identifying new anti-picornaviral compounds | Dec 10, 1998 | Issued |
Array
(
[id] => 4416789
[patent_doc_number] => 06177076
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-01-23
[patent_title] => 'Method of treating bladder cancer with wild type vaccinia virus'
[patent_app_type] => 1
[patent_app_number] => 9/206425
[patent_app_country] => US
[patent_app_date] => 1998-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1895
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/177/06177076.pdf
[firstpage_image] =>[orig_patent_app_number] => 206425
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/206425 | Method of treating bladder cancer with wild type vaccinia virus | Dec 6, 1998 | Issued |
Array
(
[id] => 4260708
[patent_doc_number] => 06258788
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-10
[patent_title] => 'DNA vaccines against tick-borne flaviviruses'
[patent_app_type] => 1
[patent_app_number] => 9/197218
[patent_app_country] => US
[patent_app_date] => 1998-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 15
[patent_no_of_words] => 11612
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/258/06258788.pdf
[firstpage_image] =>[orig_patent_app_number] => 197218
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/197218 | DNA vaccines against tick-borne flaviviruses | Nov 19, 1998 | Issued |
| 09/187057 | HUMAN PAN-HCV HUMAN MONOCLONAL ANTIBODIES | Nov 4, 1998 | Abandoned |
Array
(
[id] => 4349612
[patent_doc_number] => 06291246
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-18
[patent_title] => 'DNA virus vectors and methods for their preparation'
[patent_app_type] => 1
[patent_app_number] => 9/184987
[patent_app_country] => US
[patent_app_date] => 1998-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7149
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/291/06291246.pdf
[firstpage_image] =>[orig_patent_app_number] => 184987
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/184987 | DNA virus vectors and methods for their preparation | Nov 2, 1998 | Issued |